Additionally, the precise identification of the molecular pathways linking the loss of UTY and/or KDM5D to CD8+ T cell fatigue within the tumor microenvironment is crucial for advancing our understanding and developing targeted therapeutic strategies. The gene discussed is UTY; the disease is neoplasm.